LA ROSOLIA UNA MALATTIA NON SEMPRE PRIVA DI CONSEGUENZE = LA ROUGEOLE: UNE MALADIE QUI N'EST PAS TOUJOURS SANS CONSEQUENCESCERAMI A.1975; GAZ. MED. ITAL.; ITAL.; DA. 1975; VOL. 134; NO 1; PP. 37-38Article

POTENTIAL ANTITRYPANOSOMAL AGENTS. 1,N²-DISUBSTITUTED 2-AMINO-5-HYDROXY-4 METHYLNAPHTO (1,2-D) THIAZOLIUM SALTS AND RELATED COMPOUNDSULRICH P; CERAMI A.1982; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1982; VOL. 25; NO 6; PP. 654-657; BIBL. 18 REF.Article

THE INFLUENCE OF GENETIC BACKGROUND ON THE SUSCEPTIBILITY OF MICE TO DIABETES INDUCED BY ALLOXAN AND ON RECOVERY FROM ALLOXAN DIABETESCOHN JA; CERAMI A.1979; DIABETOLOGIA; DEU; DA. 1979; VOL. 17; NO 3; PP. 187-191; BIBL. 12 REF.Article

A GLUCOSE-CONTROLLED INSULIN-DELIVERY SYSTEM: SEMISYNTHETIC INSULIN BOUND TO LECTINBROWNLEE M; CERAMI A.1979; SCIENCE; USA; DA. 1979; VOL. 206; NO 4423; PP. 1190-1191; BIBL. 15 REF.Article

THE CURRENT STATUS OF IRON CHELATION THERAPYGRADY RW; CERAMI A.1978; ANNU. REP. MEDICIN. CHEM.; USA; DA. 1978; VOL. 13; PP. 219-226; BIBL. 2 P.Article

CHELATION THERAPY FOR THE TREATMENT OF THALASSEMIA.GRAZIANO JH; CERAMI A.1977; SEMINARS HEMATOL.; U.S.A.; DA. 1977; VOL. 14; NO 1; PP. 127-134; BIBL. 1 P. 1/2Article

THERAPY OF SICKLE CELL DISEASE. AN APPROACH WITH SODIUM CYANATE = TRAITEMENT DE LA MALADIE A CELLULES FALCIFORMES: METHODE AU CYANATE DE SODIUMPETERSON CM; CERAMI A.1974; SEMINARS HEMATOL.; U.S.A.; DA. 1974; VOL. 11; NO 4; PP. 569-576; BIBL. 1P.Article

The unexpected pathway to the creation of the HbA1c test and the discovery of AGE'sCERAMI, A.Journal of internal medicine. 2012, Vol 271, Num 3, pp 219-226, issn 0954-6820, 8 p.Article

SYNTHESIS OF HEMOGLOBIN A_IC IN NORMAL AND DIABETIC MICE: POTENTIAL MODEL OF BASEMENT MEMBRANE THICKENING.KOENIG RJ; CERAMI A.1975; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1975; VOL. 72; NO 9; PP. 3687-3691; BIBL. 18 REF.Article

THE TRYPANOCIDAL ACTIVITY OF VARIOUS AROMATIC BISGUANYLHYDRAZONES IN VIVOULRICH PC; GRADY RW; CERAMI A et al.1982; DRUG DEV. RES.; ISSN 0272-4391; USA; DA. 1982; VOL. 2; NO 2; PP. 219-228; BIBL. 25 REF.Article

THE IDENTIFICATION OF 2,3-DIHYDROXYBENZOIC ACID AS A POTENTIALLY USEFUL IRON-CHELATING DRUG = L'IDENTIFICATION DE L'ACIDE DIHYDROXY-2,3 BENZOIQUE EN TANT QU'AGENT CHELATANT LE FER EVENTUELLEMENT UTILEGRAZIANO JH; GRADY RW; CERAMI A et al.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 190; NO 3; PP. 570-575; BIBL. 18 REF.Article

BIOCHEMICAL AND RHEOLOGICAL CHARACTERIZATION OF SPUNTUM MUCINS FROM A PATIENT WITH CYSTIC FIBROSISTABACHNIK NF; BLACKBURN P; CERAMI A et al.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 14; PP. 7161-7165; BIBL. 23 REF.Article

HEMELYSIS OF THE BLOODSTREAM FORMS OF TRYPANOSOMA BRUCEI.MESHNICK SR; KWANG POO CHANG; CERAMI A et al.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 20; PP. 1923-1928; BIBL. 28 REF.Article

INCREASED HEMOGLOBIN A_IC IN DIABETIC MICE.KOENIG RJ; ARAUJO DC; CERAMI A et al.1976; DIABETES; U.S.A.; DA. 1976; VOL. 25; NO 1; PP. 1-5; BIBL. 14 REF.Article

INHIBITION OF GLUTATHIONE SYNTHESIS AS A CHEMOTHERAPEUTIC STRATEGY FOR TRYPANOSOMIASISARRICK BA; GRIFFITH OW; CERAMI A et al.1981; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1981; VOL. 153; NO 3; PP. 720-725; BIBL. 19 REF.Article

STRUCTURE OF CARBOHYDRATE OF HEMOGLOBIN A_IC.KOENIG RJ; BLOBSTEIN SH; CERAMI A et al.1977; J. BIOL. CHEM.; U.S.A.; DA. 1977; VOL. 252; NO 9; PP. 2992-2997; BIBL. 17 REF.Article

Tumor necrosis factor in the malnutrition (Cachexia) of infection and cancerTRACEY, K. J; CERAMI, A.The American journal of tropical medicine and hygiene. 1992, Vol 47, Num 1, pp 2-7, issn 0002-9637Article

Tumor necrosis factor in metabolism of disease : hormonal actions versus local tissue effectsTRACEY, K. J; CERAMI, A.Nouvelle revue française d'hématologie. 1992, Vol 34, pp S37-S42, issn 0029-4810, SUPConference Paper

Prove spermentali non destruttive per la determinazione della resistenza caratteristica cubica dei calustruzzi cementizi = Essais non destructifs pour déterminer la résistance caractéristique du béton sur éprouvettes cubiques = Non destructive testing for evaluating the characteristic strenght of concrete on cubic testing specimensCERAMI, A; LO PRESTI, S.Industria delle costruzioni. 1990, Vol 24, Num 225, pp 56-62, issn 0579-4900, 7 p.Article

Metabolic responses to cachectin/TNF : a brief reviewTRACEY, K. J; CERAMI, A.Annals of the New York Academy of Sciences. 1990, Vol 587, pp 325-331, issn 0077-8923, 7 p.Conference Paper

Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responsesSHERRY, B; CERAMI, A.The Journal of cell biology. 1988, Vol 107, Num 4, pp 1269-1277, issn 0021-9525Article

Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analoguesULRICH, P; CERAMI, A.Journal of medicinal chemistry (Print). 1983, Vol 27, Num 1, pp 35-40, issn 0022-2623Article

PROTEIN BINDING OF N-2-MERCAPTOETHYL-1,3-DIAMINOPROPANE VIA MIXED DISULFIDE FORMATION AFTER ORAL ADMINISTRATION OF WR 2721TABACHNIK NF; BLACKBURN P; PETERSON CM et al.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 2; PP. 243-246; BIBL. 11 REF.Article

DIABETIC CATARACT FORMATION: POTENTIAL ROLE OF GLYCOSYLATION OF LENS CRYSTALLINSSTEVENS VJ; ROUZER CA; MONNIER VM et al.1978; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1978; VOL. 75; NO 6; PP. 2918-2922; BIBL. 34 REF.Article

THE DEVELOPMENT OF NEW IRON-CHELATING DRUGS = LE DEVELOPPEMENT DE NOUVEAUX AGENTS CHELATEURS DU FERGRADY RW; GRAZIANO JH; AKERS HA et al.1976; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1976; VOL. 196; NO 2; PP. 478-485; BIBL. 36 REF.Article